Skip to main content

Table 4 Incidence rate ratio of clinical malaria for each SES stratum

From: Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status

Parameter

Unadjusted

Adjusted

Protective Efficacy (Percent)

95% CI

P-Value

Protective Efficacy (Percent)

95% CI

P-Value

Low SES

35.65

25.04–44.76

< 0.001

32.64

21.75–42.01

< 0.001

Medium SES

35.75

22.28–46.89

< 0.001

36.11

22.89–47.06

< 0.001

High SES

60.83

48.79–70.03

< 0.001

60.01

47.94–69.29

< 0.001

  1. Wald test and P-value for an interaction effect between participant’s SES and the treatment groups for the unadjusted model was (χ2 = 10.99, P-value = 0.0041) and was (χ2 = 11.74, P-value = 0.0028) for the adjusted model